THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM
Total 13F shares
168,594,448
Share change
-5,471,561
Total reported value
$200,534,644
Put/Call ratio
74%
Price per share
$1.19
Number of holders
148
Value change
-$7,293,146
Number of buys
63
Number of sells
57

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q2 2021

As of 30 Jun 2021, THERAPEUTICSMD INC - COM (TXMD) was held by 148 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 168,594,448 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, MORGAN STANLEY, STATE STREET CORP, RA CAPITAL MANAGEMENT, L.P., C WorldWide Group Holding A/S, GEODE CAPITAL MANAGEMENT, LLC, and AMERIPRISE FINANCIAL INC. This page lists 148 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.